Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: J Psychopharmacol. 2019 Nov 26;34(1):93–102. doi: 10.1177/0269881119872198

Figure 1. Structure of the AMPAR PAM MDI-222 (1-[4-(1-pyrrolidinylcarbonyl) phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole; Compound 9a in Ward et al., 2011).

Figure 1